Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 31 Oct 2024

Insights into the historical trajectory and research trends of immune checkpoint blockade in colorectal cancer: visualization and bibliometric analysis

in Cancer Immunity and Immunotherapy

Yonglong Chang
Xuhui Zhou
Kechao Nie
Jinhui Liu
Sifang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478773

1,663 views

Original Research

Published on 31 Oct 2024

Transcriptomics profiling of the non-small cell lung cancer microenvironment across disease stages reveals dual immune cell-type behaviors

in Cancer Immunity and Immunotherapy

Marcelo Hurtado
Leila Khajavi
Abdelmounim Essabbar
Michael Kammer
Ting Xie
Alexis Coullomb
Anne Pradines
Anne Casanova
Anna Kruczynski
Sandrine Gouin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1394965

1,708 views

Case Report

Published on 31 Oct 2024

Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient

in Cancer Immunity and Immunotherapy

Tegan Ormston
Jessica Da Gama Duarte
Luke T. Quigley
Louise Jackett
John Whitlam
Andreas Behren
David E. Gyorki

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474663

1,089 views

Mini Review

Published on 31 Oct 2024

Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Hailin Wang
Qiang Li
Qinqin Tang
Gang Shi
Guo Wu
Xingbo Mao
Changkang Wu
Lixin Zhang
Jie Liu
Jingdong Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483721

1,498 views

Review

Published on 31 Oct 2024

Critical role of non-coding RNA-mediated ferroptosis in urologic malignancies

in Cancer Immunity and Immunotherapy

Wei Li
Liying Zheng
Peiyue Luo
Tao Chen
Jun Zou
Qi Chen
Le Cheng
Lifeng Gan
Fangtao Zhang
Biao Qian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1486229

1,693 views

Original Research

Published on 31 Oct 2024

E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsiveness

in Cancer Immunity and Immunotherapy

Alf Spitschak
Prabir Dhar
Krishna P. Singh
Rosaely Casalegno Garduño
Shailendra K. Gupta
Julio Vera
Luca Musella
Nico Murr
Anja Stoll
Brigitte M. Pützer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470368

1,758 views

Original Research

Published on 31 Oct 2024

Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Wen Gao
Lifei Feng
Xinming Zhao
Zishi Huang
Duoxuan Chen
Gaofei Yin
Wei Guo
Qi Zhong
Xiaohong Chen
Jugao Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466310

1,244 views

Original Research

Published on 30 Oct 2024

Comprehensive multi-omics analysis identifies chromatin regulator-related signatures and TFF1 as a therapeutic target in lung adenocarcinoma through a 429-combination machine learning approach

in Cancer Immunity and Immunotherapy

Jun Fan
BoGuang Chen
Hao Wu
Xiaoqing Liang
Wen Shen
Xiaye Miao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481753

1,388 views

Review

Published on 30 Oct 2024

Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients

in Cancer Immunity and Immunotherapy

Vincenzo Raimondi
Rosanna Vescovini
Mattia Dessena
Gaetano Donofrio
Paola Storti
Nicola Giuliani

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483806

1,862 views

Original Research

Published on 30 Oct 2024

Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma

in Cancer Immunity and Immunotherapy

Shenbo Chen
Man Zeng
Taixue Chen
Hui Ding
JiaHan Lin
Fuyue Ye
Ran Wu
Liangwang Yang
Kun Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462064

1,708 views

Review

Published on 30 Oct 2024

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling

in Cancer Immunity and Immunotherapy

Jianhang Jiao
Yangzhi Zhao
Qimei Li
Shunzi Jin
Zhongshan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467151

1,276 views

Review

Published on 30 Oct 2024

The role of cuproptosis in gastric cancer

in Cancer Immunity and Immunotherapy

Yixian Li
Wenhao Sun
Shaolin Yuan
Xinxin Liu
Ziqi Zhang
Renjun Gu
Pengfei Li
Xin Gu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435651

2,895 views

Case Report

Published on 30 Oct 2024

Primary seminal vesicle diffuse large B-cell lymphoma: a case report and review of the literatures

in Cancer Immunity and Immunotherapy

Youli Li
Sufen Cao
Fangfang Lv
Guang-Liang Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1461090

1,593 views
1 citation

Mini Review

Published on 30 Oct 2024

A single-cell perspective on immunotherapy for pancreatic cancer: from microenvironment analysis to therapeutic strategy innovation

in Cancer Immunity and Immunotherapy

Rui Wang
Jie Liu
Bo Jiang
Benjian Gao
Honghao Luo
Fengyi Yang
Yuntao Ye
Zhuo Chen
Hong Liu
Cheng Cui

Frontiers in Immunology

doi 10.3389/fimmu.2024.1454833

1,675 views
1 citation

Review

Published on 30 Oct 2024

Oncolytic virus and CAR-T cell therapy in solid tumors

in Cancer Immunity and Immunotherapy

Eleonora Ponterio
Tobias Longin Haas
Ruggero De Maria

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455163

3,038 views
2 citations

Original Research

Published on 28 Oct 2024

Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombus

in Cancer Immunity and Immunotherapy

Wangxia Tong
Jieyue Zhong
Qiuyan Yang
Han Lin
Bolun Chen
Tao Lu
Jibing Chen
Ning Luo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1414121

2,541 views

Navigation group

Articles

Insights into the historical trajectory and research trends of immune checkpoint blockade in colorectal cancer: visualization and bibliometric analysis

Transcriptomics profiling of the non-small cell lung cancer microenvironment across disease stages reveals dual immune cell-type behaviors

Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient

Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma

Critical role of non-coding RNA-mediated ferroptosis in urologic malignancies

E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsiveness

Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma

Comprehensive multi-omics analysis identifies chromatin regulator-related signatures and TFF1 as a therapeutic target in lung adenocarcinoma through a 429-combination machine learning approach

Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients

Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling

The role of cuproptosis in gastric cancer

Primary seminal vesicle diffuse large B-cell lymphoma: a case report and review of the literatures

A single-cell perspective on immunotherapy for pancreatic cancer: from microenvironment analysis to therapeutic strategy innovation

Oncolytic virus and CAR-T cell therapy in solid tumors

Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombus